- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05097885
Health Benefits of Whole-body Vibration (VIBE-Rx)
September 20, 2023 updated by: Ryan Harris, Augusta University
Pilot Investigation on the Health Benefits of Sub Acute (12 Week) Whole-body Vibration Training
The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death in the world and many comorbid conditions (i.e.
diabetes, obesity) can affect overall CVD risk.
There is increasing interest into the role that skeletal muscle health plays in mediating CVD risk, particularly in metabolic disease states (ie.
obesity and diabetes).
Whole body vibration (WBV) has emerged as an exercise mimetic that may be more tolerable than traditional modes of exercise, such as treadmill walking/running or cycling.
Similar to traditional exercise modalities, WBV can elicit beneficial metabolic effects.
In fact, a single bout of WBV increases circulating concentrations of IL-6, which correspond with the normalization of glucose and insulin in obese individuals.
The proposed pilot investigation will provide the foundation to begin understanding the molecular and physiological mechanisms of how sub-acute WBV can improve overall CVD risk.
We hypothesize that home based WBV will decrease CVD risk by improving skeletal muscle and vascular function via a decrease in systemic inflammation.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jacob Looney, MS
- Phone Number: 7067215483
- Email: jlooney@augusta.edu
Study Contact Backup
- Name: Ryan Harris, PhD
- Phone Number: 7067215998
- Email: ryharris@augusta.edu
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- Recruiting
- Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology
-
Contact:
- Ryan Harris, PhD, CEP
- Phone Number: 706-721-5998
- Email: ryharris@augusta.edu
-
Contact:
- Casey Derella, BS
- Phone Number: 706-721-5483
- Email: cderella@augusta.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Men and women (> 18 yrs old)
- All races
Exclusion Criteria:
- <18 years old
- Clinical diagnosis of hepatic, cardiovascular, or renal disease
- Diabetic complications (i.e. macrovascular, microvascular, or autonomic)
- Pregnancy
- Direct vasoactive medications (i.e. nitrates)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sub Acute (12 week) Whole Body Training
|
Participants will be given a personal vibration plate to take home with them for training which will last for 12 weeks.
For the first four weeks, participants will be asked to complete 10 minutes of WBV per day (1 minute on and up to 1 minute of rest), at least 3-4 days per week.
At least 24 hours will be recommended in between sessions during weeks 1-4.
Beginning at week 5, participants will be asked to increase WBV time to up to 14 minutes and/or reduce the duration of rest.
Beginning at week 9, participants will be asked to increase WBV time to up to 20 minutes and/or reduce the duration of rest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in VO2 Peak
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
change from baseline relative (mL/kg/min) peak oxygen consumption (VO2) during maximal exercise test at 12 weeks
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change in Flow-Mediated Dilation (FMD)
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
change from baseline brachial artery flow mediated dilation at 12 weeks.
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change in Skeletal Muscle Mitochondrial Function
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
change from baseline skeletal muscle mitochondrial function at 12 weeks.
Measured using Near Infrared Spectroscopy (NIRS).
Values are an index of phosphocreatine recovery expressed as a rate constant (min-1)
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change in Pulse Wave Velocity (PWV)
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change from baseline PWV at 12 weeks.
Measured by Shygmocor Xcel in m/s.
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change in Post Occlusive Reactive Hyperemia (PORH)
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change from baseline PORH at 12 weeks.
Measured by Laser Speckle Contrast Imager (Moor FLPI).
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Change in IL-6
Time Frame: pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
change from baseline concentrations of Interleukin 6 (IL-6) obtained via blood draw at 12 weeks.
|
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 28, 2022
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
October 15, 2021
First Submitted That Met QC Criteria
October 27, 2021
First Posted (Actual)
October 28, 2021
Study Record Updates
Last Update Posted (Actual)
September 22, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 1818010
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Whole-body Vibration
-
Çağtay MadenCompletedWhole Body VibrationTurkey
-
Universidad de ZaragozaCentro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas... and other collaboratorsRecruitingBariatric Surgery | Bariatric Surgery and Whole Body Vibration TrainingSpain
-
University of Southern CaliforniaCompletedEffects of Whole Body Vibration Exercise on Metabolic SystemsUnited States
-
Cairo UniversityActive, not recruitingBalance | Whole Body Vibration | Rebound Therapy | cpEgypt
-
Shifa Clinical Research CenterCompletedEffect of Low Amplitude Vibration Therapy on Flexibility of Hamstring Muscle in Athletes of PakistanHamstring Contractures | Whole Body VibrationPakistan
-
Okan UniversityMedipol UniversityCompletedObesity | Exercise | Blood Pressure | Whole Body VibrationTurkey
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
Suleyman Demirel UniversityHealth Institutes of TurkeyEnrolling by invitationHypertension | Muscle Architecture | Whole Body Vibration | Carotid Intima Media ThicknessTurkey
-
Augusta UniversityNot yet recruitingOsteo Arthritis Knee | Whole Body VibrationUnited States
-
Fatih Sultan Mehmet Training and Research HospitalCompletedOsteoporosis | Whole Body VibrationTurkey
Clinical Trials on Sub Acute Whole Body Vibration Training
-
Augusta UniversityNot yet recruitingOsteo Arthritis Knee | Whole Body VibrationUnited States
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Florida State UniversityNutrisystem, Inc.CompletedHypertension | Obesity | Pre-hypertensionUnited States
-
Georgia State UniversityTerminatedFalls PreventionUnited States
-
Istanbul UniversityUnknownIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | SclerodermaTurkey
-
University Hospital, Basel, SwitzerlandCompletedItch; AthleteSwitzerland
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Universidade Federal de PernambucoUnknownRenal Transplant RecipientsBrazil
-
University of BaselUniversity Hospital, Basel, Switzerland; University Hospital of Cologne; German... and other collaboratorsUnknownChemotherapy-induced Peripheral NeuropathySwitzerland